GoodRx
About GoodRx
GoodRx helps Americans save on prescriptions. Americans spend over $400 billion a year on prescriptions, and too many people simply can't find affordable prescriptions. Even if you have insurance or Medicare. We offer a website and mobile apps that collects current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the US. GoodRx is used by thousands of physicians and millions of Americans each month. We have saved Americans over $3 billion. We are not going to rest until prescriptions are affordable for all Americans. We also offer GoodRx for Benefits, which provides technology solutions for health plans, payors and PBM's in an easy-to-understand website and mobile app experience. Learn more at www.goodrx.com/benefits.
Recent News
TandemAI Closes $22M Series A Extension Round
Don’t Give up on Your Part D Costs
Novartis Slashes 114 More Jobs at New Jersey HQ
Google March 2026 Core Update Visibility Shifts & Patterns In the US
Here’s How Much Weight-Loss Drugs Wegovy, Zepbound and Foundayo Cost — and How to Pick the Best GLP-1 for You
Strategies for Delivering Smarter Pharmacy Benefits
Strategy Pivot Hits GoodRx
10 Healthcare IT Solutions Helping Patients Navigate GLP-1 Medication Costs
Hims & Hers Launches Integrated AI‑Driven Digital Health Platform
Kaufman Investments, Two Sigma Real Estate Snap Up Boutique Office Building for $52M
How Fintech and Logistics Innovation Are Streamlining Deceased Estate Cleanouts
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
Why Men Struggle in Silence: The Hidden Link Between Mental Health and Addiction
FDA Enforcement on Copycat GLP-1's Could Reshape Retail Pharmacy Economics: Q&A with David Graziano
Descope Introduces Dedicated Identity Infrastructure for AI Agents and MCP Ecosystems
Descope Leads 2026 CIAM Rankings as Enterprises Prioritize No‑Code Identity
Pharma Pulse: Walgreens’ New Hybrid Pharmacist Model, Pharmacies Expand Injectable Access, and More
Recent Deals
No recent deals for this company.
